56
Participants
Start Date
March 31, 2013
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Spirometry test
For the initial visit for the intervention group, an initial demographics form and a health questionnaire will given to the subject to complete. To evaluate the breathing and quality of living, a spirometry test will be performed that will evaluate how well and how fast the subject can breath and blow out air.
Levalbuterol
The spirometry test will be performed with a breathing medication called Levalbuterol (Xopenex®). Levalbuterol is used in standard practice for COPD and is commonly used during spirometry.
University of Illinois, Chicago
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Illinois at Chicago
OTHER